Key Highlights

● Net Earnings fell steeply on realized repositioning losses

● Adjusted earnings eased far less

● U.S. segment improved while Japan's Margin narrowed

● Board declared a fourth-quarter dividend

Aflac Incorporated (NYSE:AFL), among the more closely followed dividend-paying insurers on the New York Stock Exchange, reported third-quarter results that showed a dramatic fall in net earnings alongside a far milder slip in adjusted earnings. The supplemental insurance group, based in Columbus, Georgia, attributed the gap mainly to realized Investment losses tied to a repositioning of its portfolio. In the same announcement, the board declared a fourth-quarter dividend, keeping the Shareholder payout on its regular schedule even as the reported Bottom Line shrank from the prior-year period.

Total revenues also fell steeply from a year earlier, and the direction of that line matters for reading the release. Aflac's Revenue includes net investment gains and losses, so a swing from gains in the prior-year quarter to sizeable losses in this one pulled the reported figure down regardless of how the underlying insurance operations performed. Premium income and investment income, the recurring sources of revenue, moved far less dramatically than the total.

The result is a quarter that can be described in sharply different ways depending on the measure chosen. Net earnings per diluted share landed at a small fraction of the year-earlier figure. Adjusted earnings per diluted share, which exclude investment gains and losses and certain other items, declined only slightly, and the decline narrowed further once the effect of a weaker yen was removed. Daniel P. Amos, the chairman and chief executive, characterized adjusted earnings for the quarter and the year to date as solid.

What Sat Behind the Investment Losses

Net investment losses represented the largest single force on reported earnings, swinging from net gains in the prior-year quarter. According to the release and a summary, the bulk of those losses arose from sales and redemptions of securities, with Derivatives and foreign currency activity and Credit loss provisions accounting for smaller portions. A further tax item, a valuation allowance related to Capital losses, also weighed on net earnings per share.

Management treated the sales as a decision rather than an accident of the market. On the earnings call, according to an automated transcript, finance chief Max Broden described so-called switch trades involving Japanese Government Bonds that are expected to lift future net investment income. Global chief investment officer Bradley Dyslin cautioned that further opportunities of this kind were becoming harder to find and that repeating the same level of impact would be difficult. That caution indicates the repositioning benefit may not extend indefinitely at the pace seen so far.

The Balance Sheet shifted as well. Total investments and cash and total Assets both fell from the prior year-end, while policy liabilities declined by a larger proportion. Net unrealized losses on securities and derivatives widened, while the discount rate effect on policy liabilities increased. Shareholders' Equity nevertheless edged higher, and Book Value per share rose by a greater margin because the share count had shrunk. Adjusted book value excluding foreign currency remeasurement, however, moved lower, offering a less flattering view than the reported figure.

Reserve Gains Lifted the Adjusted Number

Adjusted earnings deserve their own scrutiny, because they too contained a substantial non-routine element. The release disclosed sizeable reserve remeasurement gains within adjusted earnings for the quarter. Such gains arise when an insurer updates its assumptions about future claims and related experience, and their presence means that the adjusted figure is not a pure read on recurring premium and investment income. The company's annual assumption review, discussed on the call, added meaningfully to per-share results.

Securities.io made a related observation, noting that the important question for later periods is how much adjusted profitability comes from premiums, investment income and expenses rather than from reserve effects. That framing fits the segment data. Aflac Japan's margin narrowed mainly because remeasurement gains were lower than in the prior-year quarter, while Aflac U.S. benefited in part from such gains. Reserve movements therefore influenced both segments, in opposite directions.

Adjusted return on equity, excluding foreign currency remeasurement, rose modestly from the year-earlier quarter and remained high. Reported return on equity, by contrast, collapsed from its prior-year level because of the net earnings decline. Both measures are accurate on their own terms. Together, they show how far a single quarter's investment activity can separate reported returns from the figure management emphasizes when describing operating performance.

Japan: Lower Premiums and a Narrower Margin

Aflac Japan remains the larger earnings contributor, and its quarter was the softer of the main segments. Net earned premiums fell in yen terms, which the company attributed to an external Reinsurance deal in the first quarter, an internal cancer-block reinsurance arrangement in the third quarter and limited-pay policies reaching paid-up status. Adjusted net investment income rose in yen but declined after translation into dollars, illustrating the persistent currency effect on the parent's reported numbers.

Benefits and claims increased considerably in yen terms, and adjusted expenses also rose. Pretax adjusted earnings declined by a mid-teens proportion in yen and by more in dollars, while the pretax margin compressed from the prior-year level. Market data of the results showed both the benefit ratio and the expense ratio moving higher. Premium persistency also slipped slightly from a year earlier, though it remained at a high level.

New annualized premium sales in Japan declined from the year-earlier period, which had included elevated sales of the Miraito cancer product after its launch. The newer Tsumitasu savings product, refreshed during the second quarter, and the Anshin Palette product, launched in December of last year, partly offset that comparison. Year-to-date sales in Japan remained above the prior-year period, and Amos said on the call that sales for the full year were still expected to exceed the prior year's level.

The internal reinsurance transaction forms part of a broader capital strategy. Aflac Japan ceded a large block of cancer policy reserves, measured on a Japanese regulatory basis, to Aflac Re Bermuda. On the call, according to the automated transcript, Broden said the arrangement was expected to release capital. Analysts from Raymond James and elsewhere pressed management on how much further the Bermuda approach could run and how quickly the ceded proportion might rise, indicating that the question has become a point of attention for those covering the company.

The U.S. Segment Carried the Momentum

Aflac U.S. delivered the period's clearest operating improvement. Net earned premiums rose modestly, total adjusted revenues climbed and benefits and claims declined. Adjusted expenses also fell, leaving pretax adjusted earnings well above the year-earlier level and lifting the segment margin. The company credited reserve remeasurement gains, higher premiums and lower expenses for the advance, a combination that suggests a portion of the improvement was operational and a portion actuarial.

Sales in the U.S. segment increased from a year earlier, led by network dental and group life and disability products. Premium persistency improved slightly, a useful sign in a Business where retaining existing policyholders supports future earned premium. According to the automated call transcript, Virgil Miller, who leads the U.S. business, said the dental and vision platform had recovered and expressed an expectation for stronger fourth-quarter performance than a year earlier.

Management did flag an area of watchfulness. An analyst from Evercore ISI asked whether U.S. disability claims trends might prompt the company to slow its push in that market. Executives responded that exposure to behavioral health claims was small at present, that Underwriting discipline would continue, and that renewal pricing was delivering rate action. Deputy president Fred Samar said the company was keeping an eye on claim performance while viewing the environment as an opportunity for growth.

Fourth-quarter comparisons and margins remain open questions. On the call, Broden indicated that margin expectations for Japan had been raised for the year and that the U.S. margin was running above the previous guidance range. The written release itself contained no formal financial outlook, so the guidance detail comes from the call rather than from the published results document, and the transcript's automated nature calls for caution regarding fine details.

The Dividend Decision and the Buyback Pace

For readers following income stocks, the board's declaration is central. The fourth-quarter dividend is payable at the beginning of December to shareholders of record in the middle of November. The per-share amount matches the rate paid in the third quarter, which was itself higher than the payment made a year earlier. The company described its current year as a milestone in a run of annual dividend increases stretching across several decades, a record it has repeatedly highlighted in its communications.

Share repurchases accounted for considerably more cash than dividends in the quarter. Together, dividends and repurchases returned a substantial sum to shareholders, and shares outstanding at quarter-end were noticeably lower than a year earlier. That shrinking share count helps explain why adjusted Earnings Per Share fell less than total adjusted earnings. It also means that a given level of total dividend spending is spread over fewer shares, and per-share figures can improve even when aggregate earnings do not.

Amos described a balanced approach of investing in growth and driving long-term value, and spoke of tactical, opportunistic deployment of capital. Broden echoed that language on the call, saying the company intended to remain flexible and tactical. He also cited ample unencumbered Liquidity and a regulatory solvency ratio, according to the transcript. Those references indicate that capital returns remain tied to liquidity and regulatory capital rather than to the reported net earnings of any single quarter.

The Year-to-Date View and the Corporate Line

The year-to-date figures place the quarter in a calmer frame. Total revenues were lower than in the same stretch of the prior year, but by a mid-single-digit rate rather than the steep decline seen in the quarter alone. Net earnings slipped modestly, and because of the lower share count, net earnings per diluted share rose slightly. Adjusted earnings fell by a mid-single-digit rate, while adjusted earnings per diluted share were flat. Most of the repositioning pain is thus concentrated in the third quarter.

Segment trends through the year are similar in direction to the quarterly data, but less pronounced. Japan's pretax adjusted earnings fell modestly in yen and by more in dollars, with the margin narrowing only slightly. Aflac U.S. posted a high-single-digit rise in pretax adjusted earnings, with its margin widening. The Corporate and Other segment also deserves attention, since it houses the Bermuda reinsurer. Its third-quarter pretax adjusted earnings edged higher, helped by remeasurement gains and new reinsurance transactions, although lower investment income and higher expenses worked against it. For the year to date, that segment's earnings stood well below the prior-year level.

Currency, Credit and Other Items to Weigh

The yen remains an unavoidable variable. The average Exchange Rate during the quarter was noticeably weaker against the dollar than a year earlier, and this reduced adjusted earnings per share by a small amount. For the year to date, the currency drag was larger, turning a modest underlying increase in adjusted earnings per share into a flat comparison. Because Aflac reports in dollars but earns a large share of its income in yen, translation can obscure or exaggerate the operating trend in Japan.

Credit and market conditions present further considerations. The release's forward-looking language lists capital markets, interest rates, exchange rates, credit defaults and regulation among the factors capable of altering results. Credit loss provisions were one component of the quarter's investment losses. Notes payable and Lease obligations rose slightly from the prior year-end, although the change was small compared with the overall balance sheet.

Market data also pointed to filings showing a series of indirect share sales by Japan Post Holdings, a major beneficial owner, during late September and October. The summary did not link those transactions to the earnings report, and they amount to a disclosed ownership change rather than a judgment on the quarter.

Taken as a whole, the report describes an insurer willing to absorb a large reported loss on securities in exchange for what management expects to be better future investment income, while reallocating capital through internal reinsurance. The test for that strategy will lie in later quarters, when analysts can compare recurring premium and investment income with the reserve-related gains that supported this period. The dividend declaration, meanwhile, signals that the board's payout schedule continued uninterrupted through the turbulence in reported earnings.